United Therapeutics UTHR PEG ratio
PEG ratio at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's peg ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's PEG ratio?
- United Therapeutics (UTHR) reported PEG ratio of 3.2× in Q1 2026.
- How has United Therapeutics's PEG ratio changed year-over-year?
- United Therapeutics's PEG ratio increased by 324.9% year-over-year, from 0.7× to 3.2×.
- What is the long-term trend for United Therapeutics's PEG ratio?
- Over 3 years (2022 to 2025), United Therapeutics's PEG ratio has grown at a 59.8% compound annual growth rate (CAGR), from 0.3× to 1.3×.
- What does PEG ratio mean?
- The P/E ratio adjusted for how fast earnings are growing.
- How do you interpret PEG ratio?
- Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
- How does PEG ratio compare across companies?
- A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.